.jpg)
Today 31,195,121 ordinary shares of the healthcare company Arseus were successfully admitted to the regulated market of Euronext, both in Brussels and Amsterdam.
The IPO consisted of a total offering of 26,468,144 shares, raising a total of €302 million, including the over-allotment of 2,968,144 shares.
The placement was approximately two times oversubscribed.
On the basis of the IPO price of €10.25, the company’s market capitalization now totals €320 million.
Arseus is the 110th company to be listed on Euronext this year. A total of over €6.1 billion has been raised through initial public offerings on Euronext markets since the beginning of the year, representing an additional market capitalization of more than €125 billion.
Arseus (www.arseus.com ) is the Professional Health division of the Omega Pharma Group and the result of an integration of the various business-to-business activities in the group. Arseus provides all products and services for the growing market of health, wellness, aesthetics and ageing populations.
ICB sector of Arseus: 4537 Medical Supplies
Arseus is traded on the NSC platform under the following codes:
Euronext Amsterdam:Stock code: RCUSA
ISIN Code: BE0003874915
Fonds Code : 605723
Euronext Brussels:
Stock Code: RCUS
ISIN Code: BE0003874915
SVM Code: 3874.91
